The global faropenem sodium market is expected to grow at a significant CAGR during the forecast period (2021-2027). Faropenem is an oral beta-lactam antibiotic that belongs to the penem family. It is bactericidal, with a great affinity for the cell wall’s high molecular penicillin-binding proteins (PBPs), which are required for bacilli proliferation; it functions by blocking cell wall formation. Faropenem is also less vulnerable to dehydropeptidase-1 (DHP-1) than meropenem and imipenem, which are carbapenems. Faropenem is resistant to the actions of several beta-lactamases and preferentially binds to Escherichia coli (E. coli).
To Request a Sample of our Report on Faropenem Sodium Market: https://www.omrglobal.com/request-sample/faropenem-sodium-market
The rising incidences of bacterial infections, skin infection, and urinary tract infections is contributing to the growth of the global faropenem sodium market. Faropenem is approved for use in the treatment of genito-urinary infection, ear, nose, and throat infections, upper and lower respiratory tract infections, skin and skin structure infection, and gynaecological infections. Additionally, the companies are significantly focusing on manufacturing and marketing of faropenem sodium. For instance, in February 2022, Sun Pharmaceuticals has sent a proposal for manufacturing and marketing of faropenem sodium extended-release tablets. The subject expert committee which works under the Central Drugs Standard Control Organization (CDSCO), has said to present detailed pharmacokinetic data as per regulatory guidelines for review by the committee. This came after the firm presented its proposal for manufacturing and marketing of faropenem sodium extended-release tablets 300mg along with Bioequivalence study report.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Cipla Ltd., Taj Pharma (India) Ltd., and Cadila Healthcare Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Faropenem Sodium Market is Available @ https://www.omrglobal.com/industry-reports/faropenem-sodium-market
Global Faropenem Sodium Market Report by Segment
By Type
- Purity: 97%-99%
- Purity: Above 99%
By Application
- Injection
- Tablet
- Others
Global Faropenem Sodium Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
